Pharmaceuticals - Union Register


List of nationally authorised medicinal products for human use


Product name: Meronem
Also marketed in the EU under the name(s): Merrem, Optinem
Active substance: meropenem
Indication: Pneumonia, Broncho-pulmonary infections in cystic fibrosis, Complicated urinary tract infections and intra-abdominal infections, Intra- and post-partum infections, Complicated skin and soft tissue infections, Acute bacterial meningitis
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/10/2009 Referral EMEA/H/A-30/1003 (2009)8074 of 15/10/2009